Home
Scholarly Works
Irinotecan/Bevacizumab for the Treatment of...
Conference

Irinotecan/Bevacizumab for the Treatment of Refractory Brain Metastases in Patients with Her2-Neu Positive Breast Cancer

Authors

Sengupta S; Kasper E; Jeyapalan S

Volume

76

Pagination

pp. A96-A96

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Publication Date

March 1, 2011

Name of conference

63rd AAN Annual Meeting

Conference place

HI, Honolulu

Conference start date

April 9, 2011

Conference end date

April 16, 2011

Conference proceedings

NEUROLOGY

Issue

9

ISSN

0028-3878

Labels

Contact the Experts team